Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 76 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8193352

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  2. US 8188134

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  3. US 8188095

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  4. US 8188289

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 29, 2012 · Expires May 24, 2032

    granted
  5. US 8188071

    Amino substituted pyridines as potent kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  6. US 8188281

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  7. US 8188275

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 29, 2012 · Expires May 24, 2032

    granted
  8. US 8178513

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  9. US 8178534

    cMET inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  10. US 8178543

    Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  11. US 8178555

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  12. US 8173663

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 8, 2012 · Expires May 3, 2032

    granted
  13. US 8173635

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 8, 2012 · Expires May 3, 2032

    granted
  14. US 8168636

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  15. US 8168415

    Axl fusion proteins as Axl tyrosine kinase inhibitors

    The Regents of the University of Colorado · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  16. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  17. US 8163732

    Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  18. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  19. US 8158627

    Compositions and treatments using pyridazine compounds and cholinesterase inhibitors

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  20. US 8158658

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  21. US 8153644

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  22. US 8153655

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  23. US 8148367

    Renin inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  24. US 8148378

    Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

    Xenon Pharmaceuticals Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted